Injectable opioid agonist treatment for patients with opioid dependence : a review of clinical and cost-effectiveness

The purpose of this review is to summarize the evidence on the clinical effectiveness and cost-effectiveness of injectable opioid agonist treatment (with DAM or HDM, alone or in combination with methadone or buprenorphine/naloxone), compared with alternative pharmacological treatments or no treatmen...

Full description

Bibliographic Details
Main Authors: Banerjee, Srabani, Wright, Mary-Doug (Author)
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa CADTH 2020, May 27, 2020
Edition:Version: 1.0
Series:CADTH rapid response report : summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 01789nam a2200337 u 4500
001 EB001999908
003 EBX01000000000000001162809
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
100 1 |a Banerjee, Srabani 
245 0 0 |a Injectable opioid agonist treatment for patients with opioid dependence  |h Elektronische Ressource  |b : a review of clinical and cost-effectiveness  |c authors: Srabani Banerjee, Mary-Doug Wright 
250 |a Version: 1.0 
260 |a Ottawa  |b CADTH  |c 2020, May 27, 2020 
300 |a 1 PDF file (28 pages)  |b illustration 
505 0 |a Includes bibliographical references 
653 |a Analgesics, Opioid / therapeutic use 
653 |a Cost-Benefit Analysis 
653 |a Opiate Substitution Treatment / methods 
653 |a Analgesics, Opioid / administration & dosage 
653 |a Opioid-Related Disorders / drug therapy 
653 |a Treatment Outcome 
700 1 |a Wright, Mary-Doug  |e [author] 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
710 2 |a Canadian Agency for Drugs and Technologies in Health  |b Rapid Response Service 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a CADTH rapid response report : summary with critical appraisal 
856 4 0 |u http://www.ncbi.nlm.nih.gov/books/NBK564232  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 610 
520 |a The purpose of this review is to summarize the evidence on the clinical effectiveness and cost-effectiveness of injectable opioid agonist treatment (with DAM or HDM, alone or in combination with methadone or buprenorphine/naloxone), compared with alternative pharmacological treatments or no treatment, for individuals with opioid dependency